ISCIII

Inicio de sesión
Selecionar página

Publicaciones

1.       Brochado-Kith O, Martínez I, Berenguer J, Medrano LM, González-García J, Garcia-Broncano P, Jiménez-Sousa MA, Carrero A, Hontañón V, Muñoz-Fernández MA, A Fernández-Rodríguez, Resino S (*). Near normalization of peripheral blood markers in HIV-infected patients on long-term suppressive antiretroviral therapy: a case-control study. AIDS 2020, 34(13):1891-1897. (A; FI= 4.51; Q1 Infectious Diseases; JCR 2019). PMID: 32796212. DOI: 10.1097/QAD.0000000000002645.

2.       Martínez-González E, Brochado-Kith O, Gómez-Sanz A, Martín-Carbonero L, Jiménez-Sousa MA, Martínez-Román P, Resino S, Briz V (*), Fernández-Rodríguez A (*). Comparison of methods and characterization of small RNAs from plasma extracellular vesicles of HIV/HCV-coinfected patients. Sci Rep. 2020; 10(1):11140. (A; FI= 3.99; Q1 Multidisciplinary Sciences; JCR 2019). PMID: 32636456 DOI: 10.1038/s41598-020-67935-1.

3.       García-Broncano P, Medrano LM, Berenguer J, Brochado O, González-García J, Jiménez-Sousa MA, Quereda C, Sanz J, Téllez MJ, Díaz L, Jiménez JL, Muñoz-Fernández MA, Resino S (*). Mild profile improvement of immune biomarkers in HIV/HCV-coinfected patients who removed hepatitis C after HCV treatment: a prospective study. J Infect 2020; 80(1):99-110. (A; FI= 4.84; Q1 Infectious Diseases; JCR 2019). PMID: 31585189. DOI: 10.1016/j.jinf.2019.09.020.

4.       Salgüero S, Rojo D, Berenguer J, González-García J, Fernández-Rodríguez A, Brochado-Kith O, Díez C, Hontañon V, Virseda-Berdices A, Martínez J, Ibañez-Samaniego L, Llop-Herrera E, Barbas C, Resino S (*),  Jiménez-Sousa MA (*). Plasma metabolomic fingerprint of advanced cirrhosis stages among HIV/HCV-coinfected and HCV-monoinfected patients. Liver Int. 2020;40(9):2215–2227. (A; FI= 5.72; Q1 Gastroenterology & Hepatology; JCR 2019). PMID: 32593189. DOI: 10.1111/liv.14580.

5.       Molina-Carrión S, Brochado-Kith O, González-García J, Berenguer J, Díez C, Llop E, Hontañón V, Ibañez-Samaniego L, Montes ML, Resino S (*), Fernández-Rodríguez A (* ‡), Jiménez-Sousa (‡). Telomere length increase in HIV/HCV-coinfected patients with cirrhosis after HCV eradication with direct acting antivirals. J Clin Med. 2020; 9(8): e2407. (A; FI= 3.30; Q1 Medicine, General & Internal; JCR 2019). PMID: 32731419 DOI: 10.3390/jcm9082407.

6.       Jiménez-Sousa MA, Jiménez JL, Fernández-Rodríguez A, Bellón JM, Rodríguez C, Riera M, Portilla J, Castro A, Muñoz-Fernández MA, Resino S (*). DBP rs16846876 and rs12512631 polymorphisms are associated with progression to AIDS naïve HIV-infected patients: a retrospective study. J Biomed Sci 2019; 26(1):83 (A; FI= 5.76; Q1 Medicine, Research & Experimental; JCR 2019). PMID: 31640710. DOI: 10.1186/s12929-019-0577-y.

7.       Brochado-Kith O, Gómez-Sanz A, Real LM, Crespo J, Ryan P, Macías J, Cabezas J, Pineda JA, Arias-Loste MT, Díez Viñas V, Jiménez-Sousa MA, Medrano LM, Cuesta I, Monzón-Fernández S, Resino S (*), Fernández-Rodríguez A (*). MicroRNAs profile of HCV spontaneous clarified individuals denotes previous HCV infection. J Clin Med. 2019. 8(6): e849. (A; FI= 3.30; Q1 Medicine, General & Internal; JCR 2019). PMID: 31207946. DOI: 10.3390/jcm8060849.

8.       Medrano LM, García-Broncano P, Berenguer J, González-García J, Jiménez-Sousa MA, Guardiola JM, Crespo M, Quereda C, Sanz J, Canorea I, Carrero A, Hontañón V, Muñoz-Fernández MA, Resino S (*). Elevated liver stiffness is linked to increased biomarkers of inflammation and immune activation in HIV/HCV-coinfected patients. AIDS 2018, 32(9):1095-1105. (A; FI= 4.50; Q1 Infectious Diseases; JCR 2018). PMID: 29438197. DOI: 10.1097/QAD.0000000000001787.

9.       Vázquez-Morón S, Ryan P, Ardizone-Jiménez B, Martín D, Troya J, Cuevas G, Valencia J, Jiménez‑Sousa MA, Avellón A, Resino S (*). Evaluation of dried blood spot samples for screening of hepatitis C and human immunodeficiency virus in a real-world setting. Sci Rep. 2018; 8(1):1858. (A; FI= 4.01; Q1 Multidisciplinary Sciences; JCR 2018). PMID: 29382904. DOI: 10.1038/s41598-018-20312-5.

10.    Álvaro-Meca A, Palomares-Sancho I, Díaz A, Resino R, Gil A, Resino S (*). Pneumocystis pneumonia in HIV-infected patients in Spain: epidemiology and environmental risk factors. J Int AIDS Soc 2015, 18:19906. (A; FI= 6.25; D1 Infectious Diseases; JCR 2015). PMID: 25997453. DOI: 10.7448/IAS.18.1.19906.

11.    García-Álvarez M, Pineda-Tenor D, Jiménez-Sousa Ma, Fernández-Rodríguez A, Guzmán-Fulgencio M; Resino S (*). Relationship of vitamin D status with advanced liver fibrosis and response to hepatitis C virus therapy: A meta-analysis. Hepatology 2014, 6(5):1541-1550. (A; FI= 11.05; D1 Gastroenterology & Hepatology; JCR 2014). PMID: 24975775. DOI: 10.1002/hep.27281.

12.    Medrano J, Álvaro-Meca A, Boyer A, Jiménez-Sousa MA, Resino S (*). Mortality of patients infected with HIV in the intensive care unit (2005-2010): Significant role of chronic hepatitis C and severe sepsis. Crit Care 2014; 18(4):475 (A; FI= 4.47; Q1 Critical Care Medicine; JCR 2014). PMID: 25159592. DOI: 10.1186/s13054-014-0475-3.

13.    Fernández-Rodríguez A, Rallón N, Berenguer J; Jiménez-Sousa MA, Cosin J, Guzmán-Fulgencio M, Restrepo C, López JC, García-Álvarez M, Miralles P, Soriano V, Benito JM, Resino S (*). Analysis of IL28B alleles with virologic response patterns and plasma cytokine levels in HIV/HCV coinfected patients. AIDS 2013; 27(2):163-73. (A; FI= 6.55; D1 Infectious Diseases; JCR 2013). PMID: 23135173. DOI: 10.1097/QAD.0b013e32835c11e8.

14.    Jiménez-Sousa MA, Fernández-Rodríguez A, Guzmán-Fulgencio M, García-Álvarez M, Resino S (*). Meta-analysis: implication of IL28B polymorphisms in spontaneous and treatment-related clearance for patients with hepatitis C. BMC Med 2013; 11 (1):6. (A; FI= 7.28; D1 Medicine, General & Internal; JCR 2013). PMID: 23298311. DOI: 10.1186/1741-7015-11-6.

15.    Guzmán-Fulgencio M, Berenguer J; Fernández de Castro I, Micheloud D, Catalán P, López JC, Cosin J, Miralles P, Lorente R; Muñoz-Fernández MA, Resino S (*). Sustained virological response to interferon-alpha plus ribavirin decrease inflammation and endothelial dysfunction markers in HIV/HCV co-infected patients. J Antimicrob Chemoth 2011; 66(3):645-9. (A; FI= 5.07; D1 Infectious Diseases; JCR 2011). PMID: 21393232. DOI: 10.1093/jac/dkq518.